343 related articles for article (PubMed ID: 15838913)
1. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for patients with hepatocellular carcinoma.
Ho MC; Wu YM; Hu RH; Ko WJ; Yang PM; Lai MY; Lin MH; Lin HY; Lee PH
Transplant Proc; 2004 Oct; 36(8):2291-2. PubMed ID: 15561223
[TBL] [Abstract][Full Text] [Related]
6. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.
Vivarelli M; Dazzi A; Zanello M; Cucchetti A; Cescon M; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Transplantation; 2010 Jan; 89(2):227-31. PubMed ID: 20098287
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
9. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
10. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
12. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
[TBL] [Abstract][Full Text] [Related]
13. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
14. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
Pérez-Saborido B; de los Galanes SJ; Menéu-Díaz JC; Romero CJ; Elola-Olaso AM; Suárez YF; Valencia VB; Moreno-González E
Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
[TBL] [Abstract][Full Text] [Related]
15. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
Zheng SS; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Lu AW; Shao ZX
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):450-4. PubMed ID: 15854372
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma.
Kneteman NM; Oberholzer J; Al Saghier M; Meeberg GA; Blitz M; Ma MM; Wong WW; Gutfreund K; Mason AL; Jewell LD; Shapiro AM; Bain VG; Bigam DL
Liver Transpl; 2004 Oct; 10(10):1301-11. PubMed ID: 15376305
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
Park UJ; Kim YH; Kang KJ; Lim TJ
Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
[TBL] [Abstract][Full Text] [Related]
18. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK
J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
20. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]